Refresh

Suven Life Sciences Ltd. - Research Center

530239 SUVEN Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

11.69 13.54 11.84 13.48 14.41
Expenses

Material consumed

0.72 - - - -

Manufacturing expenses

0.26 - - - -

Personnel expenses

16.53 15.77 17.46 15.29 14.60

Selling expenses

- - - - -

Adminstrative expenses

25.12 25.51 31.02 28.74 35.08

Expenses capitalised

- - - - -

Cost of sales

42.63 41.28 48.49 44.03 49.68

Operating profit

-30.94 -27.74 -36.64 -30.55 -35.26

Other recurring income

21.13 8.45 5.32 7.75 14.04

Adjusted PBDIT

-9.81 -19.29 -31.33 -22.79 -21.23

Financial expenses

0.16 0.29 0.53 0.82 0.54

Depreciation

6.50 6.54 4.39 4.35 4.17

Other write offs

- - - - -

Adjusted PBT

-16.47 -26.13 -36.25 -27.95 -25.94

Tax charges

-1.00 - - -5.32 -12.18

Adjusted PAT

-15.46 - - -22.63 -13.75

Non recurring items

7.40 6.19 -0.15 -0.31 -0.30

Other non cash adjustments

- - - - -

Reported net profit

-8.07 -19.94 -36.40 -22.94 -14.05

Earnigs before appropriation

133.43 141.49 161.43 197.83 220.77

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

133.43 141.49 161.43 197.83 220.77
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com